OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Equity Capital Raises
Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
Week ended 09/27/2024
Week ended 09/27/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Week ended 09/27/2024
Equity Raises:
- On September 24, 2024, Glow LifeTech Corp. (GLOW: CSE)(GLWLF: OTCQB), a Canadian biotech company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, closed a Private Placement of Units with gross proceeds of $.89M.
- Each Unit included a whole warrant with an 18-month maturity and a 67% exercise premium. The short life and large premium reduced the value of the warrant package to less than $.001 per share.
- The transaction values the company at a market cap of approximately $2.64M and an E.V./ Annualized Revenue of roughly 3.8x.
Public vs. Private Raises:
- Both capital raisers this week are public and trade both in Canada on the CSE and in the U.S. (one on OTCQB and one on OTCQX).
Equity vs. Debt Cap Raises:
- Equity accounted for 51% of the week’s capital raise activity.
Week ended 09/27/2024
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Weekly Valuation Tracker
Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector. The Weekly Valuation Tracker provides proprietary, actionable valuation data.
- Week ended 09/27/2024
This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.
- Week ended 09/27/2024
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.